Skip to main content
Back
Watch Compare

KIORA PHARMACEUTICALS INC

Data quality: 100%
Also listed as KPHMW Nasdaq
KPRX
Nasdaq Manufacturing Chemicals
$2.49
▼ $0.37 (-12.94%)
Mkt Cap: 9.84 M
Price
$2.49
Mkt Cap
9.84 M
Day Range
$2.45 — $2.77
52-Week Range
$1.77 — $4.18
Volume
356,718
Open $2.67
50D / 200D Avg
$2.09
19.38% above
50D / 200D Avg
$2.40
3.61% above

Quick Summary

Key Takeaways

Earnings declined -401.42% over the past year
Negative free cash flow of -10.07 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)-401.42%
FCF Growth (3Y)N/A

Quality

Return on Equity
-48.66%
Above sector avg (-51.02%)
ROIC-36.17%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio8.79
Interest Coverage-642.84

Valuation

PE (TTM)
-0.91
Above sector avg (-1.98)
P/B Ratio0.44
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.9 -2.0
P/B 0.4 5.1
ROE % -48.7 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) -401.42% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -10.84 M
ROE -48.66% ROA -35.06%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -10.07 M
ROIC -36.17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.79
Interest Coverage -642.84 Asset Turnover 0.00
Working Capital 20.11 M Tangible Book Value 15.72 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.91 Forward P/E N/A
P/B Ratio 0.44 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -102.39%
Market Cap 9.84 M Enterprise Value 4.33 M
Per Share
EPS (Diluted TTM) -2.64 Revenue / Share 0.00
FCF / Share -2.55 OCF / Share -2.52
EPS CAGR (1Y) -403.45% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92.96%
SBC-Adj. FCF -10.91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 16.02 M — — 0.0
Net Income -10.84 M 3.59 M -12.51 M -13.58 M -16.39 M
EPS (Diluted) -2.64 0.87 -2.69 -18.55 -1.77
Gross Profit — — — — —
Operating Income -12.83 M 4.51 M -12.59 M -12.31 M -16.94 M
EBITDA — — — — —
R&D Expenses 10.78 M 7.84 M 4.03 M 3.45 M 5.35 M
SG&A Expenses — — — — —
D&A 24,801.0 19,205.0 51,798.0 41,609.0 45,296.0
Interest Expense 19,960.0 21,446.0 11,132.0 8,599.0 6,851.0
Income Tax -1.28 M 2.07 M 90,319.0 -113,010.0 -304,781.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 24.25 M 36.48 M 13.71 M 18.68 M 18.06 M
Total Liabilities 8.13 M 10.72 M 7.60 M 7.27 M 8.83 M
Shareholders' Equity 16.13 M 25.76 M 6.11 M 11.41 M 9.22 M
Total Debt — — — — 278,190.0
Cash & Equivalents 8.70 M 3.79 M 2.45 M 5.96 M 7.85 M
Current Assets 21.75 M 29.71 M 4.74 M 7.68 M 8.99 M
Current Liabilities 3.63 M 6.01 M 1.63 M 3.27 M 1.61 M